#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA1032269	B	Inhibition of CDKL2 at 3 uM		1	ALA1142492	single protein format	Scientific Literature
2.	ALA1052890	B	Inhibition of CDKL2 assessed as enzyme activity at 1 uM relative to untreated control		1	ALA1155237	single protein format	Scientific Literature
3.	ALA1168826	B	Inhibition of CDKL2 at 1 uM		6	ALA1165965	single protein format	Scientific Literature
4.	ALA1174171	B	Inhibition of CDKL2 at 10 uM		2	ALA1177794	single protein format	Scientific Literature
5.	ALA1244764	B	Binding affinity to CDKL2		7	ALA1240346	single protein format	Scientific Literature
6.	ALA1775873	B	Inhibition of CDKL2 at 1 uM		1	ALA1773016	single protein format	Scientific Literature
7.	ALA1826189	B	Activity of CDKL2 kinase at 1 uM		1	ALA1821651	single protein format	Scientific Literature
8.	ALA1908625	B	Binding constant for CDKL2 kinase domain		72	ALA1908390	single protein format	Scientific Literature
9.	ALA2209327	B	Inhibition of CDKL2 assessed as residual activity at 10 uM relative to control		1	ALA2203081	single protein format	Scientific Literature
10.	ALA2439140	B	Inhibition of human wild type CDKL2 at 1 uM by qPCR analysis relative to control	Homo sapiens	1	ALA2434948	single protein format	Scientific Literature
11.	ALA3624239	B	Inhibition of CDKL2 (unknown origin) at 10 uM	Homo sapiens	1	ALA3621108	single protein format	Scientific Literature
12.	ALA3887934	B	Competitive Binding Assay (KINOMEscan): For the competitive binding assay, test compounds were screened at 10 uM against 70 diverse kinase targets for competitive binding using the KINOMEscan technology (Ambit Biosciences) (Karaman, et al. (2008) Nature biotechnology 26:127-132). 11-point Kd curves were determined for hits identified during the initial screen.		1	ALA3886510	single protein format	BindingDB Database
13.	ALA4025061	B	Inhibition of wild-type human partial length CDKL2 (M1 to D327 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	Homo sapiens	1	ALA4024706	assay format	Scientific Literature
14.	ALA4031394	B	Inhibition of human CDKL2 (M1 to D327 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan assay relative to control	Homo sapiens	1	ALA4028866	assay format	Scientific Literature
15.	ALA4043872	B	Inhibition of wild-type human partial length CDKL2 (M1 to D327 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	Homo sapiens	1	ALA4043093	assay format	Scientific Literature
16.	ALA4055047	B	Inhibition of wild-type human partial length CDKL2 (M1 to D327 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	Homo sapiens	2	ALA4052645	assay format	Scientific Literature
17.	ALA4118522	B	Inhibition of human CDKL2 (1 to 327 residues) expressed in bacterial expression system assessed as enzyme activity at 1 uM by KINOMEScan assay relative to control	Homo sapiens	1	ALA4118021	assay format	Scientific Literature
18.	ALA4119090	B	Inhibition of human CDKL2 (1 to 327 residues) expressed in bacterial expression system assessed as enzyme activity at 10 uM by KINOMEScan assay relative to control	Homo sapiens	1	ALA4118021	assay format	Scientific Literature
19.	ALA4156951	B	Binding affinity to wild-type human partial length CDKL2 (M1 to D327 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	Homo sapiens	1	ALA4152344	assay format	Scientific Literature
20.	ALA4185730	B	Binding affinity to wild-type human partial length CDKL2 (M1 to D327 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	Homo sapiens	2	ALA4184148	assay format	Scientific Literature